Device Trial Radar · NCT03044054
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
113
Actual
Start
Jan 2017
Primary completion
Mar 2026
Study completion Apr 2026
Sponsor
- Lead sponsor
- TheraclionNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 6, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the efficacy and the safety of the HIFU for the treatment of breast fibroadenoma.
Conditions
- Breast Fibroadenoma
Interventions
ECHOPULSEDevice
HIFU Under ultrasound guidance
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain level assessmentTime frame: 12 Months
2 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Bellevue Hospital Center
New York, New York
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.